[Concepts of stimulating immunotherapy].
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000627:therapeutic use; D001205:Ascorbic Acid / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy; D005936:Glucans / Q000627:therapeutic use; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000276:immunology; D007154:Immune System Diseases / Q000188:drug therapy; D007288:Inosine / Q000031:analogs & derivatives*; D007542:Inosine Pranobex / Q000276:immunology* / Q000627:therapeutic use; D007978:Levamisole / Q000276:immunology* / Q000627:therapeutic use; D008213:Lymphocyte Activation / Q000187:drug effects; D009181:Mycoses / Q000188:drug therapy; D010587:Phagocytosis / Q000187:drug effects; D012397:Rosette Formation; D013601:T-Lymphocytes / Q000187:drug effects; D013951:Thymus Hormones / Q000627:therapeutic use; D013994:Tilorone / Q000627:therapeutic use; D014165:Transfer Factor / Q000627:therapeutic use; D014777:Virus Diseases / Q000188:drug therapy
D000276:Adjuvants, Immunologic; D000998:Antiviral Agents; D005936:Glucans; D013951:Thymus Hormones; D014165:Transfer Factor; D007978:Levamisole; D007288:Inosine; D013994:Tilorone; D001205:Ascorbic Acid; D007542:Inosine Pranobex
Concetti di immunoterapia stimolante.